http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005044201-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_364361dcadbe698011b0554cccff370b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77c59e3f92515676eb9718550bf2c0da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6422818fe360d8529fce8b281d459369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4087b362f3f449c37055b9c8027459d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
filingDate 2004-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e18674d204fce2d08314ffa6d90db3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_129d206aa52eeb96480134da1dbd4631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_deb1b7b70ca7f8b52d74d0df5e296410
publicationDate 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005044201-A3
titleOfInvention Ph sensitive prodrugs of 2,6-diisopropylphenol
abstract The present invention is directed to water-soluble derivatives of 2,6-diisopropylphenol (Propofol). The compounds act as prodrugs of 2,6-diisopropylphenol and metabolize rapidly to Propofol thereby providing an alternative to the water-insoluble 2,6-diisopropylphenol. Pharmaceutical compositions comprising these compounds, methods of induction and maintenance of anesthesia or sedation as well as methods of treating neurodegenerative diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
priorityDate 2003-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6254853-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6362234-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506892

Total number of triples: 37.